Dialysis 7

Embed Size (px)

Citation preview

  • 8/13/2019 Dialysis 7

    1/63

    Dialysis

  • 8/13/2019 Dialysis 7

    2/63

    Dialysis is the process of removing waste products

    and excess fluids from the body

    Definitions

    Dialysis is on of the primary modalities for pts withRF

    Dialysis can do two of the principal functions of the

    kidney; 1.removal of endogenous waste products 2.maintenance of water balance

  • 8/13/2019 Dialysis 7

    3/63

  • 8/13/2019 Dialysis 7

    4/63

    Dialysis is the process of separating elements in a

    solution by diffusion across a semipermeable

    membrane (diffusive solute transport) down aconcentration gradient

    This is the principal process for removing the end-

    products of nitrogen metabolism (urea, creatinine,uric acid), and for repletion of the bicarbonate

    deficit of the metabolic acidosis associated with

    renal failure in humans

  • 8/13/2019 Dialysis 7

    5/63

    Cont

  • 8/13/2019 Dialysis 7

    6/63

    Advanced renal failure with:

    1. Hyperkalemia

    2. Fluid overload

    3. Severe metabolic acidosis

    (PH

  • 8/13/2019 Dialysis 7

    7/63

    B. Acute dialysis

    1. ESRD with or without complications

    Cont

  • 8/13/2019 Dialysis 7

    8/63

    Signs of adequate dialysis;

    1. Well looking

    2. Eats normal

    3. Normal BP4. No oedema

    5. Normal heart size

    6. HB >=10

    7. Albumin >35

  • 8/13/2019 Dialysis 7

    9/63

    Hemodialysis

  • 8/13/2019 Dialysis 7

    10/63

    Blood is removed from the body and pumped by a

    machine outside the body into a dialyzer (artificial

    kidney)

    The dialyzer filters metabolic waste products from

    the blood and then returns the purified blood to the

    person

    The total amount of fluid returned can be adjusted

    A person typically undergoes hemodialysis at adialysis center

    Dialysate is the solution used by the dialyzer

    Cont

  • 8/13/2019 Dialysis 7

    11/63

    HD consists of perfusion of heparinized blood and

    physiologic salt solution on opposite sides of a

    semipermeable membrane

    Waste products (urea, creatinine,ets) move from

    blood into the dialysate by passive diffusion along

    concentration gradient Diffusion rate depends on;

    1. The difference between solute concentrations in the

    blood and dialysate2. Solute characteristics

    3. Dialysis filter composition

    4. Blood and dialysate flow rate

    Cont

  • 8/13/2019 Dialysis 7

    12/63

    Blood from the patient is

    circulated through a syntheticextracorporeal membrane and

    returned to the patient. The

    opposite side of that membrane

    is washed with an electrolyte

    solution (dialysate) contain- the

    normal constituents of plasma

    water

    Cont

  • 8/13/2019 Dialysis 7

    13/63

    Cont

  • 8/13/2019 Dialysis 7

    14/63

  • 8/13/2019 Dialysis 7

    15/63

    Dialysate;

    1. Water2. Glucose

    3. Acetate

    4. Bicarbonate

    5. Calcium

    6. Sodium

    7. Potassium

  • 8/13/2019 Dialysis 7

    16/63

    Used 3 times a week

    Duration; 4 hrsComplicated, need to be done in a center

    Heparin required

    Temporary arteriovenous access

    Permanent arteriovenous access

  • 8/13/2019 Dialysis 7

    17/63

    Access

    C t

  • 8/13/2019 Dialysis 7

    18/63

    The access is where the needles are placed to remove

    blood from the body and return it to the body after it

    is filtered by the dialysis machine

    Three types of accesses exist: natural fistula,

    artificial grafts, andjugular vein catheters

    A vein and an artery are joined. Within 6 to 8 weeks,

    the vein becomes much bigger and is strong enough

    to be used as an access for dialysis

    Cont

    Cont

  • 8/13/2019 Dialysis 7

    19/63

    How a fistula access works

    1.During dialysis, two needles are placed into the fistula.

    One needle will remove the blood so it can be cleaned. Theother needle will return filtered blood to the body

    2.The needles are attached by plastic tubing to a special filter

    called a dialyzer (or artificial kidney)3. A pump pushes the blood through the dialyzer. Blood

    passes on one side of the filter, and solution made by the

    machine passes on the other side. The blood does not mix

    with the solution. Instead, the solution pulls extra fluid and

    waste out of the blood by a process called dialysis

    4. The "clean" blood returns through the plastic tube. It

    passes back into the patient's body through the second needle

    Cont

    Cont

  • 8/13/2019 Dialysis 7

    20/63

    A graftis another type of access, which is used

    if a person's own veins are too small or weak to

    create a fistula. Usually, a graft is a soft,

    synthetic tube that connects to an artery at one

    end and a vein at the other. It is placed under

    the skin of the arm or thigh, like a natural vein.

    The patient's blood flows through it, like it

    flows through natural veins

    Cont

    Cont

  • 8/13/2019 Dialysis 7

    21/63

    Sometimes hemodialysis is needed right away,

    and there is no time to create a fistula or graft.

    If this happens, a tube called a cathetermaybe inserted into a large vein in the neck

    (jugular vein), behind the collarbone

    (subclavian vein)or in the groin (femoral

    vein). The patient's blood can flow through this

    tube

    Cont

  • 8/13/2019 Dialysis 7

    22/63

    Complications;

    1. Vascular access

    a. Thrombosis

    b. infection

    2. Procedure relateda. Decrease BP

    b. Headache

    c. Cramps

    d. Fever

    3. Long term

    a. Cardiovascular diseases

    b. Renal bone diseases

    c. Aluminum disease

    d. Social problems

    4. Chronic uraemia

    a. Anaemia

    b. Infection

    c. Gonadal dysfunction

    d. Increase BP

    Cont

  • 8/13/2019 Dialysis 7

    23/63

    Cont

    Cont

  • 8/13/2019 Dialysis 7

    24/63

    Cont

  • 8/13/2019 Dialysis 7

    25/63

    Standard HD

    Characteristics:1. Low permeability (low flux)

    2. Membranes are made of natural products

    (cellulose)

    3. Each session takes 4-5 hrs

  • 8/13/2019 Dialysis 7

    26/63

    Rapid high efficiency HD (RHED)

    Characteristics:1. Increase clearance of low molecular weight

    solutes (urea)

    2. Shorter procedure time

    3. Increase blood and dialysate flow rates

    4. Clearance of middle and high MW solutesincluding drugs is not increased

  • 8/13/2019 Dialysis 7

    27/63

    High flux dialysis (HFD)

    Characteristics:1. Shares the advantages of RHED

    2. Membrane pores are more open

    3. Higher clearance rate for middle molecules

    4. More expensive

    5. Needs experts to avoid large rapid fluid shift

  • 8/13/2019 Dialysis 7

    28/63

    PeritonealDialysis

    Cont

  • 8/13/2019 Dialysis 7

    29/63

    Th di l i b i th ' itCont

  • 8/13/2019 Dialysis 7

    30/63

    The dialysis membrane is the person's own peritoneum

    The dialysis fluid provides the 'container' in which waste

    products and excess water can be removed from the bodyDialysis membrane acts as a filter

    It keeps the dialysis fluid and the blood separate from

    each other, but it allows certain substances and water topass through it

    During dialysis, waste toxins and excess water pass from

    the blood into the dialysis fluid, and this is drained out ofthe body after a few hours

    A new bag of dialysis fluid is drained in, and the process

    is repeated

    Cont

    Cont

  • 8/13/2019 Dialysis 7

    31/63

    PD needs to be done every day

    PD involves draining dialysis fluid out of, and into

    the body (known as an exchange), and leavingdialysis fluid in the body while dialysis takes place

    Draining fluid out usually takes around 20 minutes

    and draining fluid in takes around 5-10 minutes

    The 'used' dialysis fluid, containing the water and

    waste (toxins) that the kidneys would normally havepassed into the urine, is drained out of the body

    The person then needs to drain between 1.5 and 3

    litres of 'new' dialysis fluid into their abdomen

    Cont

  • 8/13/2019 Dialysis 7

    32/63

    The dialysis fluid is then left inside the peritoneum to

    allow dialysis to take place. The length of time it is

    left there varies (between 1 and 8 hours), dependingon individual requirements and the type of PD

    There are no 'set' times to carry out the exchanges

    It is easy for people to adapt the timing of

    exchanges to their own needs. For example, if a

    person wants to go out for the day, they could

    delay the mid-day exchange, and do two 'quickbags' (say, 3 hours apart) after they come home

    Cont

  • 8/13/2019 Dialysis 7

    33/63

    A four-bag regime 'fits' into a typical day

    For example,

    The first bag might be exchanged before breakfast

    The second before lunch

    The third before the evening meal

    The fourth before going to bed (leaving the fluid

    for the last exchange in through the night)

    Cont

  • 8/13/2019 Dialysis 7

    34/63

    A plastic tube is permanently inserted into the abdomen

    This tube is called a PD catheter

    It is about 30 cm (12 in) long and as wide as a pencil

    The PD catheter is placed through the lower abdominal

    wall, into the peritoneal cavity

    Half of the catheter lies inside the abdomen, and half lies

    outside the body

    It comes out to one side of the navel (belly button)

    The PD catheter acts as a permanent pathway into the

    peritoneal cavity from outside the body

    Cont

  • 8/13/2019 Dialysis 7

    35/63

    Cont

  • 8/13/2019 Dialysis 7

    36/63

    The catheter is usually 'left alone' for 5 days or more

    after the operation before it is used for dialysis

    This allows it to 'settle in' and gives the abdominalwound time to heal

    PD could be done at home

    Much less efficient than HD, this is why it is used

    more frequent

    Cont

  • 8/13/2019 Dialysis 7

    37/63

    Di l t

  • 8/13/2019 Dialysis 7

    38/63

    Dialysate;1. Water

    2. Glucose

    3. Dextrose;1.5-4.25%

    4. Acetate

    5. Bicarbonate

    6. Calcium;3.5 or 2.5 mEq/l

    7. Chloride;102mEq/l

    8. Lactate;35mEq/l

    9. Magnesium;1.5mEq/l

    10. Sodium;132mEq/l to reduce themovement of sodium from the blood by

    gradient method

    11. No potassium in PD

    12. High osmolarity;350-480mOsm/L(serum=280mOsm/l) to provide a drawing force

    from the blood into the peritonium

    PET it l ilib i t t

  • 8/13/2019 Dialysis 7

    39/63

    PET; peritoneal equilibrium test

    Is a diagnostic test that determines the peritoneal

    membrane clearance and ultrafiltrationcharacteristics, and quantitates the ability to transfer

    solutes and water across the membrane

    PET results determine which type of PD isappropriate for each individual

    Indications;

  • 8/13/2019 Dialysis 7

    40/63

    Indications;

    1. DM

    2. No vascular access

    3. CVS unstable

    4. Children

    5. Old adults

    6. Pts unwilling to accept blood transfusion

    7. Severe anaemia

    8. Severe HD related symptoms e.g disequilibrium

  • 8/13/2019 Dialysis 7

    41/63

    Contraindications;

    1. Peritonea adhesion

    2. Severe lung disease

    3. Abdominal sepsis

    4. Massive polycystics

  • 8/13/2019 Dialysis 7

    42/63

    Complications;

  • 8/13/2019 Dialysis 7

    43/63

    Complications;

    a. Malnutrition

    b. Peritonitis:

    c. 70% Gm positive cocci

    d. IP antibiotic is preferred

    e. vancomicin or aminoglycosides. First dose in

    the first 2L exchange, scond dose at day 7

    f. Gentamicin 1.5 mg/kg IP in the first 2L

    exchange followed by 4-8 mg/L IP in each

    exchange for 10 days

    Cont

  • 8/13/2019 Dialysis 7

    44/63

    Cont

  • 8/13/2019 Dialysis 7

    45/63

    Cont

  • 8/13/2019 Dialysis 7

    46/63

  • 8/13/2019 Dialysis 7

    47/63

    Pharmacokinetics

    of dialysis

  • 8/13/2019 Dialysis 7

    48/63

    Factors affecting drug dialysability;

    1. Drug characteristicsA. MW; drugs with MW >500 are not dialyzable in

    the conventional HD. E.g vancomicin, digoxin

    Using high flux HD; the above mentioned drugs are

    dialyzable

    B. Water solubility; solutes which are insoluble in

    water will not easily move into aqueous dialysate,

    e.g glutethimide

    Cont

  • 8/13/2019 Dialysis 7

    49/63

    D. Volume of distribution; drugs with large VD are

    not appreciably removed by HD, e.g digoxin,

    aminoglycosides

    E. Protein binding; only unbound drugs can pass

    through the dialyser membrane, e.g phenytoin,

    propranolol, oxacillin

    Cont

  • 8/13/2019 Dialysis 7

    50/63

    2. Dialysis conditions

    A. Counter-current vs concurrent flow

    B. Blood flow rate

    C. Dialysate flow rate

    3. Membrane characteristics

    A. Thickness

    B. Material type / pore size

    C. Surface area

    Cont

  • 8/13/2019 Dialysis 7

    51/63

    Clearance of large MW drugs depends on pore size,

    surface area and flow rate

    Therapeutic considerations

  • 8/13/2019 Dialysis 7

    52/63

    Therapeutic considerations

    1. Supplementary dose should be administered post

    dialysis. If the drug is administered at the

    beginning of HD, the fraction would be removed,

    since it is not yet distributed in the body

    2. Drugs with NTW, plasma level should be

    monitored to verify the predicted estimation

    3. Drugs with wide therapeutic window, decisionbased on pts clinical status

    4 Bl d l h ld b d l 1 h

  • 8/13/2019 Dialysis 7

    53/63

    4. Blood sample should be drawn at least 1 hr post

    dialysis to allow redistribution from the tissue,

    other references recommend 6-12 hrs postdialysis

    5. Drugs which plasma concentration can be

    measured but some times no published data onthe pharmacokinetic of certain drugs. if the

    pharmacokinetics are known then replacement

    dose could be calculated6. Drugs with wide therapeutic range and serum

    concentration cannot be measured; single daily

    dose can be administered after dialysis

    C t i f d di l bilit

  • 8/13/2019 Dialysis 7

    54/63

    Categories of drug dialyzability;

    1. Dialyzable; 50% - 100% removed

    2. Moderately dialyzable; 20% - 50%

    removed

    3. Slightly dialyzable; 5% - 20% removed

    4. Not dialyzable;

  • 8/13/2019 Dialysis 7

    55/63

    Estimating the supplementary dose in dialysis pt

    1. The supplementary doses can be calculated

    from the pharmacokinetic data reported in theliterature

    2. The equations and pharmacokinetic utilized are

    based only on linear first order kinetics and one

    compartment model

    3. More complex kinetics seem to be unnecessaryfor general dosage recommendations for

    repeatedly administered drugs

    4 F t di l i th t t l l f th d

  • 8/13/2019 Dialysis 7

    56/63

    4. For pts on dialysis; the total clearance of the drog

    from the plasma (ClT) can be defined as the sum of

    the pts residential endogenous clearance and thedialysis clearance (ClD)

    i.e ClT= Cl + ClD

    If ClD>>>Cl then the drug will be eliminated much

    more rapidly during dialysis

    t1/2 0.693 X VD

    ClT=

    Clearance can be related to half l i fe by the fol lowing equation

  • 8/13/2019 Dialysis 7

    57/63

    t1/2 0.693 X VD

    Cl + ClD=

    VD is the volume of distribution of the drug

    The actual amount of drug removed by HD is the

    product of the concentration of the drug in the

    recovered dialysate and the dialysate volume

    XAmount in

    dialysate

    drug conc. in

    dialysate

    volume of

    the dialysate=

  • 8/13/2019 Dialysis 7

    58/63

    It is not clinically feasible or analytically practical to

    measure dialysate drug concentration

    This value divided by total body stores of drug prior

    to dialysis yield the actual fraction of drug removed

    by dialysis (FD)

    FD = amount of dialysate drug / TBs

    TBS = drug conc. X VD

    The following equation may be used to determine the

  • 8/13/2019 Dialysis 7

    59/63

    The following equation may be used to determine the

    fraction of the total amount of drug in the body

    removed during dialysis

    FD = 1 - e -(Cl+ClD)(t/VD)

    t is the duration of dialysis

    To use this equation, the values of Cl, ClD must be obtained

    from the literature

    Unfortunately, clearance dtat are not alwaysavailable

    Half life is more available, so we use another

    equation

    FD = 1 e -(0.693/t1/2 OD) X (t)

  • 8/13/2019 Dialysis 7

    60/63

    FD = 1 - e (0.693/t1/2OD) X (t)

    t1/2OD is the half life during dialysis

    t is the duration of dialysis

    This method can be used to calculate the fractionaldrug removed but it is inaccurate

    But it is useful in the clinical setting when clearance

    data is not available

    Example:

  • 8/13/2019 Dialysis 7

    61/63

    Example:

    NN on amikacin, Wt 70 kg

    Estimated amikacin Cl 5ml/min (endogenous

    clearance)

    Under go 4 hr HD (t OD = 4hrs)Calculate the replacement dose for NN??

    Assuming VD= 0.2 L/Kg

    ClD= 35 ml/min

    Answer:

  • 8/13/2019 Dialysis 7

    62/63

    Answer:

    ClT= Cl + ClD

    = 5 + 35 = 40 ml/min = 2.4 L/hr

    t1/2 0.693 X VD

    Cl + ClD=

    Then

    =0.693 X 0.2L/Kg X 70 Kg

    2.4 L/hr

    = 4 hrs

  • 8/13/2019 Dialysis 7

    63/63

    FD = 1 - e -(Cl+ClD)(t/VD)

    Or

    FD = 1 - e-(0.693/t

    1/2OD) X (t)

    After we get the answer. It will be replaced

    after dialysis